Filing Details

Accession Number:
0001209191-10-028756
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-05-18 13:00:00
Reporting Period:
2010-05-13
Filing Date:
2010-05-18
Accepted Time:
2010-05-18 18:56:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
949858 Oncogenex Pharmaceuticals Inc. OGXI In Vitro & In Vivo Diagnostic Substances (2835) 954343413
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1244331 Dwight Winstead 1522 217Th Pl Se, Suite 100
Bothell WA 98021
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-05-13 1,405 $2.69 1,405 No 4 M Direct
Common Stock Disposition 2010-05-13 1,405 $19.20 0 No 4 S Direct
Common Stock Acquisiton 2010-05-17 15,595 $2.69 15,595 No 4 M Direct
Common Stock Acquisiton 2010-05-17 8,260 $7.25 23,855 No 4 M Direct
Common Stock Disposition 2010-05-17 23,855 $18.53 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock stock option (right to buy) Disposition 2010-05-13 1,405 $0.00 1,405 $2.69
Common Stock Stock option (right to buy) Disposition 2010-05-17 15,595 $0.00 15,595 $2.69
Common Stock Stock option (right to buy) Disposition 2010-05-17 8,260 $0.00 8,260 $7.25
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
15,595 2008-10-28 2015-10-28 No 4 M Direct
0 2008-10-28 2015-10-28 No 4 M Direct
0 2009-05-12 2010-07-08 No 4 M Direct
Footnotes
  1. This is the weighted average price. The prices ranged from $18.40 to $18.86. The reporting person undertakes to provide on request a detailed breakout of the pricing.